The CEO of Health Insurance said more than $660 million has been allocated to subsidize 200 expensive or rare medicines. Anooshiravan Mohseni said the subsidy applies to infertility drugs and medicines for terminal diseases, ISNA reported.
Subscribe to our daily newsletter.
More from DEN Media Group:
© Financial Tribune Daily and Contributors 2014-2018